Drug Profile
NMI 8739
Alternative Names: DoprexinLatest Information Update: 26 Sep 2000
Price :
$50
*
At a glance
- Originator Protarga
- Class Obesity therapies
- Mechanism of Action Dopamine D2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Obesity
Most Recent Events
- 26 Sep 2000 Discontinued-Preclinical for Obesity in USA (Unknown route)
- 14 Sep 1998 No-Development-Reported for Obesity in USA (Unknown route)
- 11 Nov 1996 Preclinical development for Obesity in USA (Unknown route)